Brief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
14/10/2026 13:19
BRIEF-Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing Oct 14 (Reuters) - Xeris Biopharma Holdings, Inc. XERS.O:
XERIS BIOPHARMA - FILES PATENT INFRINGEMENT LAWSUITS IN U.S. DISTRICT COURT - SEC FILING
XERIS BIOPHARMA - LAWSUITS FILED AGAINST TORRENT, CYCLE, LEMED, RISING PHARMA DEFENDANTS - SEC FILING
XERIS BIOPHARMA - COMPLAINTS ALLEGE INFRINGEMENT OF '502 PATENT BY GENERIC DICHLORPHENAMIDE PRODUCTS - SEC FILING
Source text: [ID:n0001867096-26-000091]
Further company coverage: XERS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest